Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $16,080 | 9 | 89.7% |
| Food and Beverage | $1,809 | 103 | 10.1% |
| Education | $31.00 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $16,682 | 42 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $564.60 | 33 | $0 (2024) |
| GlaxoSmithKline, LLC. | $274.22 | 14 | $0 (2022) |
| Regeneron Healthcare Solutions, Inc. | $130.44 | 7 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $66.31 | 4 | $0 (2019) |
| GENZYME CORPORATION | $61.82 | 4 | $0 (2023) |
| Genentech USA, Inc. | $59.25 | 4 | $0 (2021) |
| Mylan Specialty L.P. | $34.04 | 3 | $0 (2017) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $16.37 | 1 | $0 (2017) |
| Optinose US, Inc. | $16.25 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $142.84 | 8 | AstraZeneca Pharmaceuticals LP ($92.95) |
| 2023 | $39.72 | 2 | AstraZeneca Pharmaceuticals LP ($20.28) |
| 2022 | $136.57 | 8 | AstraZeneca Pharmaceuticals LP ($67.35) |
| 2021 | $10,467 | 31 | Teva Pharmaceuticals USA, Inc. ($10,190) |
| 2020 | $166.25 | 9 | GlaxoSmithKline, LLC. ($66.06) |
| 2019 | $197.86 | 12 | AstraZeneca Pharmaceuticals LP ($90.14) |
| 2018 | $6,505 | 22 | Teva Pharmaceuticals USA, Inc. ($6,346) |
| 2017 | $265.29 | 22 | Teva Pharmaceuticals USA, Inc. ($133.16) |
All Payment Transactions
114 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.61 | General |
| Category: Respiratory | ||||||
| 11/20/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/06/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: Respiratory | ||||||
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Education | In-kind items and services | $23.32 | General |
| Category: Respiratory | ||||||
| 09/18/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.84 | General |
| Category: Respiratory | ||||||
| 08/07/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $15.48 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 07/24/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: Respiratory | ||||||
| 06/27/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 09/27/2023 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $19.44 | General |
| 03/15/2023 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $20.28 | General |
| Category: Respiratory | ||||||
| 12/07/2022 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $12.63 | General |
| Category: IMMUNOLOGY | ||||||
| 10/05/2022 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $12.50 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/14/2022 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $14.26 | General |
| Category: Respiratory | ||||||
| 04/27/2022 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: IMMUNOLOGY | ||||||
| 03/16/2022 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $21.52 | General |
| Category: Respiratory | ||||||
| 02/23/2022 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $25.91 | General |
| Category: IMMUNOLOGY | ||||||
| 02/21/2022 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: Respiratory | ||||||
| 02/02/2022 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: Respiratory | ||||||
| 12/08/2021 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.83 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/27/2021 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $9.54 | General |
| Category: Respiratory | ||||||
| 09/29/2021 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: Immunology | ||||||
| 09/27/2021 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: Respiratory | ||||||
| 08/18/2021 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: IMMUNOLOGY | ||||||
| 08/17/2021 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: Respiratory | ||||||
| 08/11/2021 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $12.85 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 254 | 3,495 | $68,397 | $30,181 |
| 2022 | 10 | 339 | 4,514 | $88,139 | $40,327 |
| 2021 | 9 | 365 | 4,879 | $94,621 | $45,157 |
| 2020 | 10 | 360 | 3,390 | $78,282 | $35,130 |
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 106 | 202 | $18,173 | $11,133 | 61.3% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2023 | 16 | 650 | $11,375 | $6,010 | 52.8% |
| 95004 | Test for allergy using allergenic extract | Office | 2023 | 36 | 2,323 | $20,907 | $5,730 | 27.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 36 | 47 | $6,157 | $3,692 | 60.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 22 | 22 | $3,388 | $1,432 | 42.3% |
| 95117 | Professional service for multiple injections of allergen | Office | 2023 | 17 | 208 | $6,032 | $1,419 | 23.5% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 21 | 43 | $2,365 | $765.20 | 32.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 127 | 244 | $21,946 | $13,861 | 63.2% |
| 95004 | Test for allergy using allergenic extract | Office | 2022 | 47 | 3,034 | $27,306 | $8,325 | 30.5% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2022 | 18 | 730 | $12,775 | $7,256 | 56.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 46 | 54 | $7,074 | $4,405 | 62.3% |
| 95117 | Professional service for multiple injections of allergen | Office | 2022 | 20 | 340 | $9,860 | $2,397 | 24.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 19 | 19 | $2,926 | $1,322 | 45.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 11 | 11 | $2,409 | $1,216 | 50.5% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 27 | 58 | $3,190 | $984.91 | 30.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 12 | 12 | $355.00 | $320.84 | 90.4% |
| 90688 | Influenza vaccine, quadrivalent, 0.5 ml dosage | Office | 2022 | 12 | 12 | $298.00 | $240.84 | 80.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 141 | 301 | $26,775 | $17,432 | 65.1% |
| 95004 | Injection of allergenic extracts into skin, accessed through the skin | Office | 2021 | 53 | 3,412 | $30,708 | $9,335 | 30.4% |
| 95165 | Preparation and provision of single or multiple antigens for allergen immunotherapy | Office | 2021 | 20 | 690 | $12,075 | $7,251 | 60.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 53 | 62 | $8,122 | $5,690 | 70.1% |
| 95117 | Injection of incremental dosages of allergen, 2 or more injections | Office | 2021 | 20 | 316 | $9,164 | $2,293 | 25.0% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 31 | 31 | $4,774 | $1,798 | 37.7% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Office | 2021 | 25 | 45 | $2,475 | $965.70 | 39.0% |
| 90688 | Vaccine for influenza for administration into muscle, 0.5 ml dosage, quadrivalent | Office | 2021 | 11 | 11 | $253.00 | $219.01 | 86.6% |
About Dr. Charles Lowe, MD
Dr. Charles Lowe, MD is a Allergy & Immunology healthcare provider based in Pikeville, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1104854207.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Charles Lowe, MD has received a total of $17,920 in payments from pharmaceutical and medical device companies, with $142.84 received in 2024. These payments were reported across 114 transactions from 11 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($16,080).
As a Medicare-enrolled provider, Lowe has provided services to 1,318 Medicare beneficiaries, totaling 16,278 services with total Medicare billing of $150,795. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Practice Information
- Specialty Allergy & Immunology
- Location Pikeville, KY
- Active Since 06/28/2006
- Last Updated 12/20/2013
- Taxonomy Code 207K00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1104854207
Products in Payments
- QVAR (Drug) $6,358
- AirDuo RespiClick (Drug) $5,040
- ArmonAir Digihaler (Drug) $3,360
- ProAir Digihaler (Drug) $1,680
- FASENRA (Drug) $246.91
- FASENRA (Biological) $210.25
- NUCALA (Biological) $196.97
- DUPIXENT (Biological) $145.78
- CINQAIR (Drug) $120.82
- AirDuo Digihaler (Drug) $109.87
- AIRSUPRA (Drug) $92.95
- BREO (Drug) $77.25
- Xolair (Biological) $59.25
- ASMANEX (Drug) $49.81
- Dymista (Drug) $34.04
- DUPIXENT (Drug) $27.04
- JANUVIA (Drug) $16.50
- SPIRIVA (Drug) $16.37
- Xhance (Drug) $16.25
- PRE-PEN (Drug) $15.27
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.